Bad Blood

A charismatic college dropout in a black turtleneck promised to revolutionize medicine with a machine that could run hundreds of blood tests from a single finger-prick, raised hundreds of millions of dollars, and put a device on the market that did not work. Carreyrou, the reporter who broke the story, reconstructs the rise and collapse of the company from the inside, drawing on interviews with terrified former employees and a paper trail of intimidation. What makes the book so propulsive is that it reads like a thriller while being scrupulous nonfiction, tracing how a culture of secrecy, fear, and true-believer loyalty let a fraud grow inside a Silicon Valley darling. The reporting is granular: faked demonstrations, blood diluted to hide that the machines could not handle real samples, and aggressive lawyers deployed against anyone who tried to speak. This suits readers who want a clear-eyed account of ambition curdling into deception, and anyone interested in how technology hype and lax oversight can endanger real patients. It fits less well readers hoping for a balanced psychological portrait, since the book is firmly an indictment built from evidence. The scene in which the author realizes his own sources are being surveilled shows how far the intimidation reached. Told with the pace of a legal drama and the rigor of investigative journalism, it stands as one of the most propulsive true accounts of a modern corporate collapse, and a warning about believing a founder simply because everyone else does.

Best for readers who want to be kept on edge: propulsive, twisty, and hard to put down. The prose is accessible: you can read this quickly and it never asks too much of you. It moves quickly: once you're in, it's hard to stop. Readers who prefer character depth over plot drive may find it thin.